Urinary tract infections in patients with type II diabetes mellitus in the parish of el Anegado
DOI:
https://doi.org/10.62305/biosana.v5i2.456Keywords:
beta-lactams; enterobacteria; glucose; susceptibility; urinary tractAbstract
In patients with type 2 diabetes, there are studies showing that these infections caused by enterobacteria and other uropathogens remain prevalent, due to their vulnerability to the disease itself. The objective of the study was to evaluate urinary tract infections in patients suffering from type II diabetes mellitus in the parish of El Anegado. The methodology used consisted of a quantitative, observational, descriptive, cross-sectional cohort design; the type of sample was simple random, the sample was 100 patients. Results: By urine culture were identified 2 species of Escherichia coli (17%) and Klebsiella pneumoniae (6%, susceptibility to Escherichia coli showed 13 strains resistance to Amoxicillin-clavulanic acid, 1 strain was intermediate, amikacin 12 sensitive strains and 5 strains intermediate and higher resistance to Amoxicillin-clavulanic acid and cephalotin the predisposing factors of the urinary tract were urinary incontinence, diseases in the urinary tract and previous urinary tract procedure, presented the value p <0.000 * as significant risk factors for this type of infection in diabetic patients. Conclusion: Escherichia coli was the most identified enterobacteria in urinary tract infections in diabetic patients with a high resistance to Amoxicillin-clavulanic acid, in addition to predisposing factors with statistical significance such as urinary incontinence.
Downloads
References
Organización Mundial de la Salud. Organización Mundial de la Salud. [Online].; 2021. Available from: https://www.who.int/es/campaigns/world-diabetes-day/2021/key-messages.
Carriel M, Ortiz J. Prevalencia de infección del tracto urinario y perfil de susceptibilidad antimicrobiana en Enterobacterias. Vive Rev. Salud. 2021; 4(11): p. 217-228; https://doi.org/10.33996/revistavive.v4i11.89; http://www.scielo.org.bo/scielo.php?script=sci_arttext&pid=S2664-32432021000200104.
Hamid, M y col. Diabetes-associated infections: development of antimicrobial resistance and possible treatment strategies. Arch Microbiol. 2020; 202(5): p. 953–965; doi: 10.1007/s00203-020-01818-x; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223138/.
Organización Mundial de la Salud. Organización Mundial de la Salud. [Online].; 2021. Available from: https://www.who.int/es/news-room/fact-sheets/detail/antimicrobial-resistance.
Organización Mundial de la Salud. Organización Mundial de la Salud. [Online].; 2021. Available from: https://www.who.int/es/news/item/01-10-2021-who-prioritizes-access-to-diabetes-and-cancer-treatments-in-new-essential-medicines-lists.
Portes J y col. Infección de vías urinarias en pacientes con diabetes mellitus tipo 2: prevalencia, factores de riesgo y perfil infeccioso. Revista Sanitaria de Investigación. 2021; 2(4): p. https://dialnet.unirioja.es/servlet/articulo?codigo=8055542.
Neira J y col. etoacidosis en pacientes diabéticos con infecciones de Vías respiratorias y vías urinarias. REVISTA AVFT. 2022; 41(11): p. 765-768; https://doi.org/10.5281/zenodo.7521120; https://www.proquest.com/openview/8b7440cf5a911fe04070ec4b77333085/1?pq-origsite=gscholar&cbl=1216408.
Lucas E y col. Infección urinaria en pacientes con diabetes mellitus tipo 2: frecuencia, etiología, susceptibilidad antimicrobiana y factores de riesgo. Kasmera. 2018; 46(2): p. 139-151; https://pesquisa.bvsalud.org/portal/resource/pt/biblio-1008107.
Jagadeesan y col. Urinary tract infection and Diabetes Mellitus—Etio-clinical profile and antibiogram: A North Indian perspective. J Family Med Prim Care. 2022; 11(5): p. 1902-1906; doi: 10.4103/jfmpc.jfmpc_2017_21.
Diriba y col. Identification of Bacterial Uropathogen and Antimicrobial Resistance Patterns Among Patients with Diabetic and Hypertension Attending Dilla University General Hospital, Dilla, Ethiopia. Infect Drug Resist. 2023; 16: p. 4621-4633; doi: 10.2147/IDR.S417033.
Bhatt y col. A rare urinary tract infection of multidrug-resistant Chryseobacterium urinae sp. nov. isolated from a diabetic, non-catheterized patient. Arch Microbiol. 2024; 206(150): p. doi: 10.1007/s00203-024-03881-0.
Woldemariam. Common uropathogens and their antibiotic susceptibility pattern among diabetic patients. Enfermedad de BMC Infect. 2019; 19(43): p. doi: 10.1186/s12879-018-3669-5.
Zang y col. Pathogenic Bacteria and Antimicrobial Resistance in Hospital-Acquired Urinary Tract Infections among Patients with Diabetic Nephropathy. Arch Esp Urol. 2024; 77(7): p. 779-788; doi: 10.56434/j.arch.esp.urol.20247707.109.
Kande y col. Prevalence of uropathogens and their antimicrobial resistance pattern among adult diabetic patients. Indian J Public Health. 2021; 65(3): p. 280-286; doi: 10.4103/ijph.IJPH_1413_20.
Oumer y col. Bacterial uropathogens, their associated factors, and antimicrobial susceptibility pattern among adult diabetic patients in two health centers at Kombolcha town, Northeastern Ethiopia. SAGE Open Med. 2022; 10: p. 1-11; doi: 10.1177/20503121221139149.
Oyemomi y col. Asymptomatic bacteriuria in patients with type 2 diabetes mellitus in rural southwestern Nigeria: a cross-sectional study. J Int Med Res. 2024; 52(3): p. doi: 10.1177/03000605241233515.
Sonkoue y col. Multidrug-Resistant Escherichia coli Causing Urinary Tract Infections among Controlled and Uncontrolled Type 2 Diabetic Patients at Laquintinie Hospital in Douala, Cameroon. Can J Infect Dis Med Microbiol. 2022; 2022: p. doi: 10.1155/2022/1250264.
Abdulkair y col. Antimicrobial susceptibility of Escherichia coli isolated from diabetic patients in Mogadishu, Somalia. Front Microbiol. 2023; 14(1204052): p. doi: 10.3389/fmicb.2023.1204052.
Ahmad y col. Diabetes mellitus and urinary tract infection: Causative uropathogens, their antibiotic susceptibility pattern and the effects of glycemic status. Pak J Med Sci. 2020; 36(7): p. doi: 10.12669/pjms.36.7.2881.
Khalid y col. Case Report: Urinary Tract Infection in a Diabetic Postmenopausal Woman With Multiple Episodes of Recurrence: An Antimicrobial Susceptibility dispute. Clin Med Insights Case Rep. 2022; 15: p. 10.1177/11795476221112819.
Yi y col. Optimizing Antibiotic Treatment for Urinary Tract Infections secondary to E. coli in Elderly Diabetic Patients: Considering Age and Blood Glucose Control. Urol Int. 2024; 16: p. doi: 10.1159/000541435.
Burekovic y col. Correlation Between Inflammatory and Biochemical Parameters in Patients with Diabetes and Urinary Tract Infection. Mater Sociomed. 2021; 33(4): p. doi: 10.5455/msm.2021.33.240-243.
Dai y col. Incidence and risk factors of asymptomatic bacteriuria in patients with type 2 diabetes mellitus: a meta-analysis. Endocrine. 2023; 82(2): p. doi: 10.1007/s12020-023-03469-6.
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 BIOSANA Health Scientific Journal. ISSN 2960-8481
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
